Article
Evo 2 Predicts Cardiomyopathy-Associated Variants and Elucidates Their Underlying Mechanisms
2026-05-17
Abstract excerpt
<h4>Background</h4> Although advances in next-generation sequencing have accelerated the identification of genetic variants in cardiomyopathy, interpreting variants of uncertain significance (VUS) remains a clinical challenge. Evo 2 is a high-resolution genomic artificial intelligence model capable of predicting pathogenicity across large sequence contexts and enabling mechanistic interpretation; however, its app...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- eb53ef6c-89d5-5fd2-b9ef-263b9801f037
- DOI
- 10.64898/2026.05.15.725304
